|
The RIQAS ToRCH quarterly EQA programme is designed to monitor the performance of 12 infectious diseases that can lead to congenital abnormalities.
- Liquid ready to use samples for ease of use and convenience
- 100% human plasma mirrors the performance of patient samples
|
Cat no: |
RQ9152 |
|
Vial size: |
5 x 1ml (samples shipped 4 times per year) |
Frequency: |
Quarterly reporting (1 x 12 month cycle), Qualitative results only |
| Cycle Start Date: |
25 June 2012 (Cycle will run from June 2012 to March 2013) |
Parameters: |
Anti-Toxoplasma IgG
Anti-Toxoplasma IgM
Anti-Rubella IgG
Anti-Rubella IgM
Anti-CMV IgG
Anti-CMV IgM
Anti-HSV1 IgG
Anti-HSV1 IgM
Anti-HSV2 IgG
Anti-HSV2 IgM
Anti-HSV-1&2 IgG (combined)
Anti-HSV-1&2 IgM (combined) |
Please contact marketing@randox.com if you would like to participate |